Search
for
Sort by
Research 151–180 of 1000+
- A CLINICAL STUDY OF ALOPECIA AREATA AND TO EVALUAT E OF THE EFFICACY OF 0.03% TOPICAL TACROLIMUS IN ITS TREATMENT
- Lupus erythematosus: systemic and cutaneous manifestations
- Dermatological Manifestations of COVID-19 Patients
- Development and Validation of a Quality of Life Measurement for Chronic Skin Disorders in French: VQ-Dermato
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Geriatric Dermatologic Therapy
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- The Assessment and Treatment of Geezers
- Concomitant Alopecia Areata and Profound Bone Marrow Suppression: An Unusual Manifestation of Azathioprine Toxicity
- Trichohyalin is a Potential Major Autoantigen in Human Alopecia Areata
- Cutaneous drug reactions
- 54269 Patchy hair loss, hyperpigmented plaques, and hyperkeratotic papules in a middle aged woman
- Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation
- Neuropeptídeos na pele
- A study of COVID‐19 vaccine (Covishield) induced dermatological adverse effects from India
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- The treatment of alopecia areata
- Laser-Induced Koebner-Related Skin Reactions: A Clinical Overview
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Finasteride in Androgenic Alopecia
- Neuroimmunoendocrine circuitry of the ‘brain-skin connection’
- Malnutrition and Allergies: Tipping the Immune Balance towards Health
- Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata
- Efficacy and safety of very-low-dose oral minoxidil 1.25 mg in male androgenetic alopecia
- Immunomodulators in the treatment of cutaneous lymphoma
- A Systematic Review of 207 Studies Describing Validation Aspects of the Dermatology Life Quality Index
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- COVID‐19 dermatological manifestations: results from the Mexican Academy of Dermatology COVID‐19 registry